Dna X Inc (SONM) — 13F Holders Deep Dive (Q2 2026)

SONM ranks #10294 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

SONM is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

9 institutions disclose a position in SONM, but none treat it as a major bet — even C2C Wealth Management, LLC, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

BlackRock has added to its SONM position for two straight quarters, increasing it by $28.0K to reach $72.1K today.

SONM reported a net loss of $8.5M over the trailing twelve months.

• Not yet profitable — net loss of $8.5M over the trailing twelve months
• Revenue grew 21.0% year over year
• Net income improved year over year, from -$31.1M to -$8.5M
• Operating cash flow was negative, using $23.5M in cash
• Current ratio of 0.60x — below the conventional 1.5x liquidity buffer
• Liabilities run 50625.00x equity — a highly leveraged balance sheet worth noting